Global Pharma Services / CDMO
Challenge
A global pharma services company faced increasing sustainability expectations from customers, private equity owners, and future capital market stakeholders. The company needed credible GHG emissions data, investor-grade reporting, and a sustainability program that could scale across dozens of global sites.
Work performed
- Scope 1-3 carbon accounting foundation
- GHG Protocol-aligned methodology
- Scope 3 category prioritization and enhancement
- Supplier-informed emissions data workflows
- Activity-based modeling for priority Scope 3 categories
- Automated utility data integrations across global sites
- Site, supplier, and data quality validation
- Assurance-ready reporting workflows
Results
- Built a fully integrated sustainability program
- Improved customer and investor readiness
- Strengthened ability to respond to major customer sustainability requests
- Reduced burden on internal teams through more repeatable workflows
- Positioned the company for future regulation, investor review, and potential capital events